Statement Re: Appointment to NHS GP IT Futures InPublic Statement Re: Appointment to <org value="ACORN:0318615332" idsrc="">NHS</org> GP IT Futures


Appointment to NHS GP IT Futures

DXS International plc (“DXS”), the healthcare information and digital clinical decision support systems provider, is pleased to announce that it has been awarded a place on the new NHS GPIT Futures framework. This framework, beginning on the 1st January 2020, will enable GP Practices to purchase  DXS products and services funded centrally by the NHS rather than from their own practice funds.

This GPIT Futures award follows an evaluation of a tender to The Health & Social Care Information Centre (known as NHS Digital).

GPIT Futures replaces the current GPSoC2 framework, where DXS is currently an accredited Supplier of Clinical Decision Support to UK Primary Care, and where our Core Solution, DXS Point of Care is currently centrally funded by the NHS. All approved products and services will be placed on the NHS Digital Online Buying Catalogue that will make it easy for GP Practices to purchase DXS products and services.

All Suppliers that have achieved this award will be required to meet separate approval for their products and services.  DXS has already made substantial progress towards satisfying these requirements.

The DXS Board is extremely positive about this development that adds three new DXS products, into which we have been making significant investment, on to the centrally funded catalogue.

David Immelman, DXS CEO commented:

“I am delighted that the DXS’ team’s hard work, dedication and expertise have been rewarded by this award. This is an exciting time for DXS to realise increased revenue growth and improve patient outcomes by bringing our new Long-Term Condition management health care solutions to market – particularly as they will be supported by central funding. These solutions, in which we have invested over a number of years, all present significant efficiency savings to both GP Practices and the NHS.

The Directors of DXS International plc accept responsibility for this announcement.


David Immelman   (Chief Executive)
DXS International plc
01252 719800 

Corporate Advisor

City & Merchant
David Papworth

020 7101 7676


Corporate Broker

Hybridan LLP
Claire Noyce

020 3764 2341


Note to Editors:

About DXS

DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively which should significantly contribute towards the NHS achieving its projected efficiency savings.